These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53. Current and novel drug therapies for idiopathic pulmonary fibrosis. Adamali HI; Maher TM Drug Des Devel Ther; 2012; 6():261-72. PubMed ID: 23055696 [TBL] [Abstract][Full Text] [Related]
58. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study). Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y; Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274 [TBL] [Abstract][Full Text] [Related]
59. Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis. Hilberg O; Simonsen U; du Bois R; Bendstrup E Clin Respir J; 2012 Jul; 6(3):131-43. PubMed ID: 22697264 [TBL] [Abstract][Full Text] [Related]
60. Administration of nintedanib after discontinuation for acute exacerbation of idiopathic pulmonary fibrosis: a case report. Ikeda S; Sekine A; Baba T; Yamakawa H; Morita M; Kitamura H; Ogura T BMC Pulm Med; 2016 Mar; 16():38. PubMed ID: 26940352 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]